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Dedicated to the memory of Professor Gaspare Barone (1943–2005)Abstract
Lansoprazole and omeprazole degrade in water leading to sulﬁdes, benzimidazolones and a red complex material.
Degradation is accelerated in acid medium and by solar simulator irradiation. Benzimidazoles, dianilines and pyridines
have also been identiﬁed.
 2005 Elsevier Ltd. All rights reserved.
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The occurrence of pharmaceuticals in surface waters
and the question as to whether they pose a risk to the
environment are receiving considerable attention (Ku¨m-
merer, 2001). Most of the literature on this subject con-
cerns the occurrence of drugs and their eﬀects on
selected aquatic organisms, while few data are reported
on the transformation products of drugs. In this context,
we have recently studied the abiotic transformation of
selected anti-inﬂammatory drugs in the aquatic environ-
ment and we have found that some degradation prod-
ucts are more harmful than the parent compounds
(DellaGreca et al., 2004).0045-6535/$ - see front matter  2005 Elsevier Ltd. All rights reserv
doi:10.1016/j.chemosphere.2005.09.003
* Corresponding author. Tel.: +39 081 674122; fax: +39 081
674393.
E-mail address: previter@unina.it (L. Previtera).In recent years, the importance of non-biological
alteration in the breakdown of drugs has been widely
noticed and there are in progress a large number of
researches concerning degradation mechanisms, kinet-
ics, isolation and toxicity of degradation products. The
last aspect is of particular interest since the metabolites
may be even more toxic than the parent molecule. Our
objective in this study was to determine the main prod-
ucts of hydrolytic and photolytic cleavage of two substi-
tuted pyridylmethylsulﬁnyl benzimidazole derivatives:
lansoprazole (1a) and omeprazole (1b), proton pump
inhibitors (PPIs) widely used for treatment of acid-
related diseases (Horn, 2000) (Fig. 1). Omeprazole has
been recently found in surface waters of the Lambro
river (Calamari et al., 2003). Stability studies have been
conducted especially on omeprazole and have revealed
that it is acid labile and sensitive to light and heat (Wall-
mark and Lindberg, 1987), suggesting the possibleed.
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Fig. 1. Drug structures.
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lems have been observed in the establishment of the anal-
ysis of the pharmaceuticals and corresponding impurities
(Castro et al., 1999; El-Kousy and Bebawy, 1999; Kar-
ljikovic-Rajic et al., 2003). However, in these studies
there is no characterization of the degradation products.2. Material and methods
2.1. Chemicals
Lanzoprazole (1a) and omeprazole (1b) were
obtained from (Sigma) and used as received. All the
other chemicals have been purchased from Aldrich.
2.2. Equipment and methods
Nuclear magnetic resonance (NMR) spectra were
recorded at 500 MHz for [1H] and 125 MHz for [13C]
on a Fourier Transform NMR Varian 500 Unity Inova
spectrometer. Carbon multiplicity was evidenced by
DEPT experiments. The proton couplings were evi-
denced by 1H–1H COSY experiments. The heteronu-
clear chemical shift correlations were determined by
HMQC and HMBC pulse sequences.
Electronic impact mass spectra (EI-MS) were
obtained with a HP 6890 spectrometer equipped with a
MS 5973 N detector. Infrared spectra (IR) were deter-
mined on a Fourier Transform Infrared Perkin–Elmer
1740 spectrometer in CHCl3 solutions (0.025 M). Ultra-
violet spectra (UV) were recorded in ethanol (104 M)
on a Perkin–Elmer LAMBDA 7 spectrophotometer.
Irradiation experiments were performed with a 150 W
solar simulator equipped with a Xenon lamp. The lamp
had a spectral output 200–2.400 nm and an irradiance at
0.5 m higher than 10 mW m2 nm1; a ﬁlter was used to
simulate irradiation at the earth surface (Oriel
Instruments).
2.3. Experimental procedure
Dispersions were prepared by suspending the drug
(40 mg) in milliQ water (500 ml). Experiments at pH
7.1 were carried out using the same concentration in
pure water, buﬀered with NaH2PO4/Na2HPO4, and atpH 4.0 or 9.0 by adjusting the pH values using HCl
2 M or KOH 2 M, respectively.
In a typical procedure, each dispersion of the drug
was kept in the dark or irradiated at room temperature
(in the latter case, the sample was irradiated from the
top and maintained in a thermostated pyrex beaker).
The water was then evaporated, and the residue was ﬁrst
analyzed by 1H NMR and then chromatographed by
TLC with Merck Kieselgel 60 F254 plates with 1 mm ﬁlm
thickness. The dispersions investigated at pH 4.0 or 9.0
were neutralized before water evaporation.
Experiments in the presence of humic acids (5 ppm)
and KNO3 (10 ppm) were carried out using the same
concentration of the drug and then analyzing the mix-
ture in the dark or by irradiation as above.
Experiments were carried out using the same concen-
tration of the drug in closed pyrex tube after saturating
with oxygen or argon and then analyzing the mixture in
the dark or by irradiation, as above.
2.3.1. Hydrolysis products isolation
The dispersion of lansoprazole (40 mg) in water
milliQ (500 ml), kept in the dark for 72 h, led, after
evaporation of water, to a red-coloured residue (30 mg).
The latter was chromatographed on preparative TLC
[CH2Cl2/(CH3)2CO (9:1)] aﬀording sulﬁde 2a (10%),
lansoprazole (1a) (57%), a red fraction (17%) and benz-
imidazolone 3a (3%) at decreasing Rfs.
The dispersion of omeprazole (1b), kept in the dark
for 43 h, led, after water evaporation, to an intense
red-coloured residue which was separated on prepara-
tive TLC [CH2Cl2/CH3OH (95:5)], giving compound
2b (25%), omeprazole (20%), an intractable red fraction
(15%) and compound 3b (10%), at decreasing Rfs.
The red fractions deriving from both drugs consisted
of diverse products (TLC and 1H NMR, data not
shown). Attempts to separate and/or characterize the
red materials failed due to their alteration over time or
during chromatographic processes.
2.3.2. Photoproducts isolation
The dispersion of lansoprazole (40 mg) in milliQ
water (500 ml), irradiated by solar simulator for 72 h,
after water evaporation, gave a residue (38 mg) which
was puriﬁed on preparative TLC [CHCl3/CH3OH
(95:5)] giving sulﬁde 2a (10%), dianiline 5a (8%), fraction
M. DellaGreca et al. / Chemosphere 63 (2006) 1087–1093 1089A (16 mg), a red fraction (15%), benzimidazole 4a (5%)
and benzimidazolone 3a (5%) at decreasing Rfs. Frac-
tion A (16 mg) was puriﬁed on preparative TLC
[CH2Cl2/CH3OH (97:3)] giving dianiline 5a (11%), pyri-
dine 6a (5%), lansoprazole (24%) at decreasing Rfs.
A suspension of omeprazole (80 ppm) in water milliQ
was exposed to the solar simulator for 43 h. After eva-
poration of water, the residue (25 mg) was chroma-
tographed on TLC [CH2Cl2/CH3OH (95:5)] leading, at
decreasing Rfs, to dianiline 5b (10%), sulﬁde 2b (16%),
benzimidazolone 3b (20%), pyridine 6b (traces, <1%)
benzimidazolone 4b (traces, <1%) and a red fraction
(20%).2.4. Photostability of derivatives 2, 3, and 4
Suspensions of benzimidazoles 3a, 4a, 3b and 4b
(10 ppm) in MilliQ water were exposed to the solar sim-
ulator for 72 or 43 h. Each experiment was performed in
duplicate, with one set of dark controls. Each reaction
mixture was evaporated in vacuum and each residue
was analysed by 1H NMR and TLC showing only the
starting material.
When sulﬁdes 2a and 2b were treated in the same
way, analysis of dark samples showed only starting
materials, while by irradiation they led to a mixture of
products. The mixture from 2a (8 mg) was subjected to
preparative TLC [CH2Cl2/CH3OH (93:7)] aﬀording
dianiline 5a (30%) and benzimidazole 4a (38%). The
mixture (7 mg) deriving from irradiation of 2b was sub-
jected to preparative TLC [CH2Cl2/CH3OH (93:7)] giv-
ing dianiline 5b (43%) and benzimidazole 4b (28%).N
H
N
S
N
H3C O
CF3
O
O
7a
3
1
7
4
1' 6'
5'
5
6
Fig. 2. Sulfone 7a structure.2.5. Products characterization
Compounds 3a and 4a were identiﬁed by comparing
spectral data with those of commercial samples (from
Aldrich). Compounds 4b and 6b were identiﬁed by 1H
NMR and LC-MS due to their low amounts.
Compound 2a: EIMS m/z 353 [M]+; IR (CHCl3):
mmax3100 (NH), 1581 (C@N), 1168 (CF3) cm
1; UV kmax
208, 292 nm; 1H NMR: d (CD3OD) 8.27 (1H, d,
J = 5.6 Hz, H-6 0), 7.50 (2H, br s, H-4, H-7), 7.22 (2H,
m, H-5, H-6), 7.02 (1H, d, J = 5.6 Hz, H-5 0), 4.70 (2H,
q, J = 8.4, CH2CF3), 4.59 (2H, s, CH2S), 2.29 (3H, s,
CH3).
13C NMR: d (CD3OD) 163.0 (C-4 0), 155.5 (C-
2 0), 149.4 (C-6 0), 147.5 (C-2), 139.8 (C-8, C-9), 122.1
(C-5, C-6), 123.0 (C-3 0), 122.0 (CF3), 113.0 (C-4, C-7),
106.4 (C-5 0), 64.8 (CH2CF3), 36.1 (CH2S), 9.3 (CH3).
Compound 6a: EIMS m/z 221 [M]+; IR (CHCl3):
mmax 3357 (OH), 1592 (C@N), 1170 (CF3) cm
1; 1H
NMR: d (CD3OD) 8.33 (1H, d, J = 5.5 Hz, H-6 0), 7.06
(1H, d, J = 5.5 Hz, H-5 0), 4.82 (2H, q, J = 8.4,
CH2CF3), 4.62 (2H, s, CH2OH), 2.13 (3H, s, CH3).
13C NMR: d (CD3OD) 164.2 (C-4 0), 160.3 (C-2 0),148.7 (C-6 0), 122.6 (C-3 0), 120.0 (CF3), 108.3 (C-5 0),
67.2 (OCH2), 64.5 (CH2OH), 10.3 (CH3).
Compound 2b: EIMS m/z 329 [M]+; IR (CHCl3):
mmax 3100 (NH), 1591 (C@N), cm
1; UV kmax 214,
300 nm; 1H NMR: d (CD3OD) 8.13 (1H, s, H-6 0), 7.38
(1H, d, J = 8.8, H-7), 7.00 (1H, d, J = 2.4, H-4), 6.81
(1H, dd, J = 8.8, 2.4 Hz, H-6), 4.54 (2H, s, CH2S),
3.79 (3H, s, OCH3), 3.74 (3H, s, OCH3), 2.24 (3H, s,
CH3), 2.22 (3H, s, CH3).
13C NMR: d (CD3OD) 166.4
(C-4 0), 158.1 (C-5), 155.6 (C-2 0), 149.8 (C-6 0), 150.3 (C-
2), 140.8 (C-9), 135.0 (C-8), 127.7 (C-3 0), 127.3 (C-5 0),
116.1 (C-4), 113.1 (C-6), 97.8 (C-7), 60.6 (OCH3), 56.2
(OCH3), 37.8 (CH2S), 13.4 (CH3), 11.3 (CH3).
Compound 3b: EIMS m/z 164 [M]+; IR (CHCl3):
mmax 3140 (NH), 1720 (C=O) cm
1; 1H NMR: d
(CD3OD) 6.92 (1H, d, J = 8.0, H-7), 6.66 (1H, d,
J = 2.5, H-4), 6.63 (1H, dd, J = 8.5, 2.5 Hz, H-6), 3.77
(3H, s, OCH3).
13C NMR: d (CD3OD) 158.4 (C-2),
157.0 (C-5), 131.6 (C-9), 124.7 (C-8), 110.7 (C-7), 108.6
(C-6), 96.9 (C-4), 56.2 (OCH3).
Compound 4b: EIMS m/z 148 [M]+; 1H NMR: d
(CD3OD) 8.04 (1H, s, H-2), 7.47 (1H, d, J = 9.0, H-7),
7.09 (1H, br s, H-4), 6.90 (1H, dd, J = 9.0, 2.5 Hz,
H-6), 3.83 (3H, s, OCH3).
Compound 5b: EIMS m/z 138 [M]+; IR (CHCl3):
mmax 3290 and 3195 (NH2 stretching), 1626 (NH2 bend-
ing) cm1; 1H NMR: d (CD3OD) 7.08 (1H, d, J = 9.4,
H-6), 6.78 (2H, m, H-2, H-5), 3.79 (3H, s, OCH3).
13C
NMR: d (CD3OD) 157.1 (C-1), 133.4 (C-3), 126.7
(C-4), 110.5 (C-6), 110.2 (C-5), 94.7 (C-2), 55.1 (OCH3).
Compound 6b: EIMS m/z 167 [M]+; 1H NMR: d
(CD3OD) 8.14 (1H, s, H-6), 4.66 (2H, s, CH2O), 3.80
(3H, s, OCH3), 2.29 (3H, s, CH3), 2.26 (3H, s, CH3).
2.6. Synthesis of 2-((4-(2,2,2-triﬂuoroethoxy)-
3-methylpyridin-2-yl)methylsulfonyl)-1H-
benzo[d]imidazole (7a) (Fig. 2)
To a solution of compound 1a (18 mg) in anhydrous
dichloromethane (0.02 M), m-chloroperbenzoic acid (1
equiv.) was added and the resulting mixture kept at
room temperature under magnetic stirring. After two
hours, TLC showed that compound 1a disappeared.
Then, the mixture was washed with water and anhydri-
ﬁed with Na2SO4. After ﬁltration and evaporation of
dichloromethane, the sulfone 7a was puriﬁed by TLC
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[M]+; IR (CHCl3): mmax 3198 (NH), 1581 (C@N), 1341
(SO2), 1172 (CF3), 1144 (SO2) cm
1; 1H NMR: d
(CDCl3) 8.27 (1H, d, J = 5.3 Hz, H-6
0), 7.65 (2H, br s,
H-4, H-7), 7.37 (2H, m, H-5, H-6), 6.68 (1H, d,
J = 5.3 Hz, H-5 0), 5.10 (2H, s, SO2CH2), 4.37 (2H, q,
J = 8.4, CH2CF3), 2.35 (3H, s, CH3).
13C NMR: d
(CDCl3) 164.0 (C-4
0), 162.5 (C-2 0), 148.1 (C-6 0), 147.5
(C-2), 147.3 (C-8, C-9), 128.1 (C-5, C-6), 125.4 (C-3 0),
125.3 (CF3), 115.0 (C-4, C-7), 106.5 (C-5
0), 65.3
(CH2CF3), 60.2 (CH2SO2), 11.4 (CH3).
When the sulfone was dispersed in milliQ water and
kept in the dark, analysis by TLC and 1H NMR after
72 h showed the sulfone unchanged.3. Results and discussion
The drugs have been dispersed in water and kept in
the dark or irradiated with a solar simulator. Table 1
reports all the experimental conditions used and the
results of the most signiﬁcant tests. The reaction mix-
tures were analyzed by NMR spectroscopy indicating
the presence of diﬀerent degradation products. Percent-
age yields of products were evaluated by chromatogra-
phy of each mixture. The products (Scheme 1) were
identiﬁed by their spectroscopic features and/or by com-
parison with authentic samples. Both lansoprazole and
omeprazole were unstable in water decomposing in
about 40% and 80%.
Sulﬁdes 2 and benzimidazolones 3 and a red-col-
oured mixture were isolated from the mixtures. Unfortu-Table 1
Photolysis and hydrolysis of lansoprazole (1a)a and omeprazole (1b)b
Drugc Products (%)d
Condition 1a 2a 3a
1a Lighte 24 10 5
1a Dark 57 10 3
1a pH 7.0/lighte 22 5 8
1a pH 7.0/dark 100 – –
1a pH 4.0/dark 50 20 5
1a pH 9.0/dark 100 – –
1b 2b 3b
1b Lighte – 16 20
1b Dark 20 25 10
1b pH 7.0/lighte 5 12 20
1b pH 7.0/dark 100 – –
1b pH 4.0/dark – 50 28
1b pH 9.0/dark 100 – –
a Reaction time 72 h.
b Reaction time 43 h.
c 40 mg in 500 ml of milliQ water.
d By TLC.
e By a solar simulator.nately, attempts to characterize the red material failed
due to its complexity and changeable nature. However,
the presence of diverse and labile substances in the de-
gradation of these drugs has been previously reported
(Brandstrom et al., 1989). Probably, this red material
consists of a mixture of degradation products very labile
and particularly sensitive to silica. Experiments con-
ducted at diﬀerent pHs indicated that degradation was
accelerated in acid conditions, while according to previ-
ous results by Lagerstro¨m and Persson (1984) the drugs
were quite stable at pH 9.0 or 7.0.
Degradation is accelerated by light (1a and 1b exhibit
absorption bands at kmax 292 and 300 nm, respectively).
After 72 h in milliQ water, lansoprazole was present
only for 24% while after 43 h omeprazole was com-
pletely degraded. The photoinduced degradation is par-
ticularly evidenced if one compares the results at
buﬀered pH 7.0 with those at the same conditions in
the dark where the drugs are stable. Photodegradation
was not aﬀected by the presence of humic acids or
nitrate, which are often found to act as photosensitizers
(Zepp et al., 1985, 1987), indeed the same products in the
same yields were obtained by irradiating the drugs in the
presence of these additives.
Product distribution either by hydrolysis or irradia-
tion appeared not to be aﬀected under argon-saturated
conditions.
Control experiments showed that sulﬁdes 2a and 2b
were stable to hydrolysis while by irradiation they led
to dianilines 5 and benzimidazoles 4 almost quantita-
tively, as expected, due to the absorption bands at kmax
292 and 300 nm similar to those of the respective parentin diﬀerent conditions
Red material 4a 5a 6a
15 5 19 5
17 – – –
8 5 19 3
– – – –
15 – – –
– – – –
Red material 4b 5b 6b
20 <1 10 <1
15 – – –
15 <1 16 <1
– – – –
14 – – –
– – – –
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Scheme 1. Isolated degradation products from drugs 1 in aqueous suspension.
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ones 3 resulted stable both to hydrolysis and to
photolysis.
As shown in Table 1, dark degradation is signiﬁcant,
leading mainly to sulﬁdes 2. A possible pathway is
reported in Scheme 2 and is based on the literature data.
Sulﬁdes 2 have been evidenced mainly under physiologi-
cal pH in the presence of thiols in a model for studying
the mechanism of (H+–K+)-ATPase inhibition by sulfox-
ides (Im et al., 1985; Sturm et al., 1987; Brandstrom et al.,
1989). Their formation was explained by assuming that
the sulfoxides rearrange in acidic media to a spirointer-
mediate 8 which through subsequent steps, involving
reaction with thiols, leads to the sulﬁdes, which contain
the original molecular backbone (Lindberg et al.,
1986). In our case, the formation of sulﬁdes cannot be
easily justiﬁed in this way, while benzimidazolones 3
could be formed by hydrolysis of spirointermediate 8
due to the easy N–S bond breakage (Umetsu et al.,
1980). Another pathway is possible for formation of sul-
ﬁdes 2. It is reported that aromatic sulfoxides are frag-
mented and/or reduced via cations or radical cations as
9 and the conversion which may be slow if the acid is
weak, occurs more easily with heterocyclic compounds
(Shine, 1967). So, the alteration of drugs 1 might be
due to the mild acid medium (initially measured ca. pH
5.0) as foreseen on the basis of the pKas at 3.83 for 1a
and 4.06 for 1b (Shin et al., 2004). Therefore, it is likely
that protonation leads to radical cation 9 and OH radical
formation which might trigger oxidation reactions, pre-sumably on the aromatic groups of the drugs, leading
to sulﬁdes 2 and the red material. This hypothesis agrees
with recent studies which have evidenced the anti-oxi-
dant role of lansoprazole and omeprazole as OH-radical
scavengers during ulceration in addition to their acting as
proton pump inhibitors (Biswas et al., 2003). The authors
identiﬁed only sulfones among four oxidation products
formed by incubation of the drug with Cu2+-ascorbate
system. In our experiments no sulfone was detected. This
was evidenced by control experiments showing that sul-
fone 7a (ad hoc prepared) was found to be stable in dark
conditions. The faster degradation of omeprazole might
be due to the presence of activating groups such as 5-
OMe or Me on the pyridinium moiety which should
favor the oxidation.
When irradiated, the degradation of both drugs is
accelerated. The identiﬁed products are benzimidazoles
4, dianilines 5 and pyridines 6 in addition to sulphides
2, benzimidazolones 3 and the red material. By irradia-
tion, the excited drug undergoes a series of fragmenta-
tions which are diﬃcult to rationalize due to the low
concentration of other unidentiﬁed products and low
mass balance. It has been ascertained that photodegra-
dation does not involve oxygen. So, compounds 6 might
form by decomposition of an unstable sulfenate interme-
diate (Still, 1988; Hogg, 1990).
Compounds 4 and 5might form via simple homolytic
benzimidazole–sulfoxide and/or -sulﬁde bond cleavage
(Still, 1988) or photoinduced water addition to the benz-
imidazole moiety.
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The work reports the chemical and photochemical
behaviour of lanzoprazole and omeprazole in the aqua-
tic environment. Both drugs result stable enough at pH
7.0 or higher while mild acid medium or solar light
induce signiﬁcant degradation, so justifying the diﬃculty
of their determination (Karljikovic-Rajic et al., 2003).
Redox reactions and fragmentations are mainly
involved and do not require oxygen. This aspect is of
particular interest and ﬁts in with recent observations
that these drugs act as both proton pump inhibitors
(Horn, 2000) and as anti-oxidant and anti-apoptotic
agents (Biswas et al., 2003).Acknowledgements
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